Małgorzata Opydo-Chanek (Malgorzata Opydo-Chanek, Małgorzata Opydo)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Induced Apoptosis

Top Venues

Journal of medicinal chemistry

International journal of molecular sciences

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska, Kamil Kaminski, Andrzej Mogielnicki, Krzysztof Szczubiałka
Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of medicinal chemistry 66 (3) (2023)
Małgorzata Opydo-Chanek, Anna Mlyczyńska, Ewa Mlyczyńska, Agnieszka Rak, Elzbieta Kolaczkowska
Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation. International journal of molecular sciences 24 (8) (2023)
Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska, Kamil Kaminski, Andrzej Mogielnicki, Krzysztof Szczubiałka
Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of medicinal chemistry 66 (3) (2023)
Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska, Kamil Kaminski, Andrzej Mogielnicki, Krzysztof Szczubiałka
Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of medicinal chemistry 66 (3) (2023)
Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska, Kamil Kaminski, Andrzej Mogielnicki, Krzysztof Szczubiałka
Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of medicinal chemistry 66 (3) (2023)
Małgorzata Opydo-Chanek, Anna Mlyczyńska, Ewa Mlyczyńska, Agnieszka Rak, Elzbieta Kolaczkowska
Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation. International journal of molecular sciences 24 (8) (2023)
Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska, Kamil Kaminski, Andrzej Mogielnicki, Krzysztof Szczubiałka
Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of medicinal chemistry (2023)
Małgorzata Opydo-Chanek, Anna Mlyczyńska, Ewa Mlyczyńska, Agnieszka Rak, Elzbieta Kolaczkowska
Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation. International journal of molecular sciences 24 (8) (2023)
Małgorzata Opydo-Chanek, Anna Mlyczyńska, Ewa Mlyczyńska, Agnieszka Rak, Elzbieta Kolaczkowska
Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation. International journal of molecular sciences 24 (8) (2023)
Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska, Kamil Kaminski, Andrzej Mogielnicki, Krzysztof Szczubiałka
Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of medicinal chemistry 66 (3) (2023)
Iwona Cichon, Weronika Ortmann, Michal Santocki, Małgorzata Opydo-Chanek, Elzbieta Kolaczkowska
Scrutinizing Mechanisms of the 'Obesity Paradox in Sepsis': Obesity Is Accompanied by Diminished Formation of Neutrophil Extracellular Traps (NETs) Due to Restricted Neutrophil-Platelet Interactions. Cells 10 (2) (2021)
Małgorzata Opydo-Chanek, Iwona Cichoń, Agnieszka Rak, Elżbieta Kołaczkowska, Lidia Mazur
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells. Investigational new drugs 38 (6) (2020)